Document is current
Any future updates will be listed below
-
Authors
Chen, Shengze
Zhang, Haoyang
Luo, Qiang
You, Shuang
Du, Pengfei
Chen, Leichong
Zhang, Dejun
Meng, Rui
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82373228)
National Health Commission of the People's Republic of China (2024ZD0525900)
Department of Science and Technology, Hubei Provincial People's Government (2024AFD440)
Department of Science and Technology, Hubei Provincial People's Government (2022CFB070)
Guangdong Association of Clinical Trials (GACT) /Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (CTONG-YC20220118)
Beijing Xisike Clinical Oncology Research Foundation (Y-zai2022/ms-0190 and Y-2024AZ(EGFR)MS-0041)
- License Information
-
More Information
Article History
Received: 26 January 2026
Accepted: 13 August 2026
First Online: 4 September 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: This manuscript has been read and approved by all the authors to publish and is not submitted or under consideration for publication elsewhere.
Competing interests: The authors declare no competing interests.
